Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Mol Cell Proteomics ; 15(1): 109-23, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26527623

ABSTRACT

Cancer is a very heterogeneous disease, and biological variability adds a further level of complexity, thus limiting the ability to identify new genes involved in cancer development. Oncogenes whose expression levels control cell aggressiveness are very useful for developing cellular models that permit differential expression screenings in isogenic contexts. HMGA1 protein has this unique property because it is a master regulator in breast cancer cells that control the transition from a nontumorigenic epithelial-like phenotype toward a highly aggressive mesenchymal-like one. The proteins extracted from HMGA1-silenced and control MDA-MB-231 cells were analyzed using label-free shotgun mass spectrometry. The differentially expressed proteins were cross-referenced with DNA microarray data obtained using the same cellular model and the overlapping genes were filtered for factors linked to poor prognosis in breast cancer gene expression meta-data sets, resulting in an HMGA1 protein signature composed of 21 members (HRS, HMGA1 reduced signature). This signature had a prognostic value (overall survival, relapse-free survival, and distant metastasis-free survival) in breast cancer. qRT-PCR, Western blot, and immunohistochemistry analyses validated the link of three members of this signature (KIFC1, LRRC59, and TRIP13) with HMGA1 expression levels both in vitro and in vivo and wound healing assays demonstrated that these three proteins are involved in modulating tumor cell motility. Combining proteomic and genomic data with the aid of bioinformatic tools, our results highlight the potential involvement in neoplastic transformation of a restricted list of factors with an as-yet-unexplored role in cancer. These factors are druggable targets that could be exploited for the development of new, targeted therapeutic approaches in triple-negative breast cancer.


Subject(s)
Breast Neoplasms/metabolism , HMGA1a Protein/metabolism , Proteome/metabolism , Proteomics/methods , ATPases Associated with Diverse Cellular Activities , Blotting, Western , Breast Neoplasms/diagnosis , Breast Neoplasms/genetics , Carrier Proteins/genetics , Carrier Proteins/metabolism , Cell Cycle Proteins , Cell Line, Tumor , Disease-Free Survival , Gene Expression Regulation, Neoplastic , HMGA1a Protein/genetics , Humans , Immunohistochemistry , Kaplan-Meier Estimate , Kinesins/genetics , Kinesins/metabolism , Mass Spectrometry , Membrane Proteins/genetics , Membrane Proteins/metabolism , Multivariate Analysis , Prognosis , Proteome/genetics , RNA Interference , Reverse Transcriptase Polymerase Chain Reaction , Translational Research, Biomedical/methods
2.
PLoS One ; 8(7): e69866, 2013.
Article in English | MEDLINE | ID: mdl-23936116

ABSTRACT

High Mobility Group A proteins (HMGA1 and HMGA2) are architectural nuclear factors involved in development, cell differentiation, and cancer formation and progression. Here we report the cloning, developmental expression and functional analysis of a new multi-AT-hook factor in Xenopus laevis (XHMG-AT-hook) that exists in three different isoforms. Xhmg-at-hook1 and 3 isoforms, but not isoform 2, are expressed throughout the entire development of Xenopus, both in the maternal and zygotic phase. Localized transcripts are present in the animal pole in the early maternal phase; during the zygotic phase, mRNA can be detected in the developing central nervous system (CNS), including the eye, and in the neural crest. We show evidence that XHMG-AT-hook proteins differ from typical HMGA proteins in terms of their properties in DNA binding and in protein/protein interaction. Finally, we provide evidence that they are involved in early CNS development and in neural crest differentiation.


Subject(s)
High Mobility Group Proteins/genetics , Morphogenesis/genetics , RNA, Messenger/genetics , Xenopus laevis/genetics , Amino Acid Sequence , Animals , Cell Differentiation , Central Nervous System/cytology , Central Nervous System/growth & development , Central Nervous System/metabolism , Embryo, Nonmammalian , Eye/cytology , Eye/growth & development , Eye/metabolism , Gene Expression Regulation, Developmental , High Mobility Group Proteins/metabolism , Molecular Sequence Data , Neural Crest/cytology , Neural Crest/growth & development , Neural Crest/metabolism , Protein Binding , RNA, Messenger/metabolism , Sequence Alignment , Sequence Homology, Amino Acid , Xenopus laevis/growth & development , Xenopus laevis/metabolism , Zygote/cytology , Zygote/growth & development , Zygote/metabolism
3.
PLoS One ; 8(2): e56469, 2013.
Article in English | MEDLINE | ID: mdl-23451052

ABSTRACT

We have identified a 101-amino-acid polypeptide derived from the sequence of the IIA binding site of human albumin. The polypeptide contains residues that make contact with IIA ligands in the parent protein, and eight cysteine residues to form disulfide bridges, that stabilize the polypeptide structure. Seventy-four amino acids are located in six α-helical regions, while the remaining thirty-seven amino acids form six connecting coil/loop regions. A soluble GST fusion protein was expressed in E. coli in yields as high as 4 mg/l. This protein retains the IIA fragment's capacity to bind typical ligands such as warfarin and efavirenz and other albumin's functional properties such as aldolase activity and the ability to direct the stereochemical outcome of a diketone reduction. This newly cloned polypeptide thus represents a valuable starting point for the construction of libraries of binders and catalysts with improved proficiency.


Subject(s)
Peptides/chemistry , Peptides/metabolism , Recombinant Fusion Proteins/metabolism , Serum Albumin/chemistry , Albumins , Catalysis , Glutathione Transferase/chemistry , Humans , Protein Binding , Recombinant Fusion Proteins/chemistry
4.
PLoS One ; 8(1): e53750, 2013.
Article in English | MEDLINE | ID: mdl-23326497

ABSTRACT

PRMT6 is a protein arginine methyltransferase that has been implicated in transcriptional regulation, DNA repair, and human immunodeficiency virus pathogenesis. Only few substrates of this enzyme are known and therefore its cellular role is not well understood. To identify in an unbiased manner substrates and potential regulators of PRMT6 we have used a yeast two-hybrid approach. We identified 36 new putative partners for PRMT6 and we validated the interaction in vivo for 7 of them. In addition, using invitro methylation assay we identified 4 new substrates for PRMT6, extending the involvement of this enzyme to other cellular processes beyond its well-established role in gene expression regulation. Holistic approaches create molecular connections that allow to test functional hypotheses. The assembly of PRMT6 protein network allowed us to formulate functional hypotheses which led to the discovery of new molecular partners for the architectural transcription factor HMGA1a, a known substrate for PRMT6, and to provide evidences for a modulatory role of HMGA1a on the methyltransferase activity of PRMT6.


Subject(s)
Nuclear Proteins/metabolism , Protein-Arginine N-Methyltransferases/metabolism , Chromatography, Affinity , HMGA1a Protein/metabolism , Humans , Models, Biological , Protein Binding , Protein Interaction Domains and Motifs , Protein Interaction Mapping , Reproducibility of Results , Substrate Specificity , Two-Hybrid System Techniques
5.
Sci Rep ; 2: 251, 2012.
Article in English | MEDLINE | ID: mdl-22355763

ABSTRACT

High-mobility group AT-hook 1 (HMGA1) protein is an important nuclear factor that activates gene transcription by binding to AT-rich sequences in the promoter region of DNA. We previously demonstrated that HMGA1 is a key regulator of the insulin receptor (INSR) gene and individuals with defects in HMGA1 have decreased INSR expression and increased susceptibility to type 2 diabetes mellitus. In addition, there is evidence that intracellular regulatory molecules that are employed by the INSR signaling system are involved in post-translational modifications of HMGA1, including protein phosphorylation. It is known that phosphorylation of HMGA1 reduces DNA-binding affinity and transcriptional activation. In the present study, we investigated whether activation of the INSR by insulin affected HMGA1 protein phosphorylation and its regulation of gene transcription. Collectively, our findings indicate that HMGA1 is a novel downstream target of the INSR signaling pathway, thus representing a new critical nuclear mediator of insulin action and function.

6.
J Proteome Res ; 10(7): 3283-91, 2011 Jul 01.
Article in English | MEDLINE | ID: mdl-21545188

ABSTRACT

The architectural factors HMGA are highly connected hubs in the chromatin network and affect key cellular functions. HMGA have a causal involvement in cancer development; in fact, truncated or chimeric HMGA forms, resulting from chromosomal rearrangements, lack the constitutively phosphorylated acidic C-terminal tail and display increased oncogenic potential, suggesting a functional role for this domain. HMGA belong to the intrinsically disordered protein category, and this prevents the use of classical approaches to obtain structural data. Therefore, we combined limited proteolysis, ion mobility separation-mass spectrometry (IMS-MS), and electrospray ionization-mass spectrometry (ESI-MS) to obtain structural information regarding full length and C-terminal truncated HMGA forms. Limited proteolysis indicates that HMGA acidic tail shields the inner portions of the protein. IMS-MS and ESI-MS show that HMGA proteins can assume a compact form and that the degree of compactness is dependent upon the presence of the acidic tail and its constitutive phosphorylations. Moreover, we demonstrate that C-terminal truncated forms and wild type proteins are post-translationally modified in a different manner. Therefore, we propose that the acidic tail and its phosphorylation could affect HMGA post-translational modification status and likely their activity. Finally, the mass spectrometry-based approach adopted here proves to be a valuable new tool to obtain structural data regarding intrinsically disordered proteins.


Subject(s)
Chromatin/chemistry , HMGA Proteins/chemistry , Proteomics/methods , Recombinant Proteins/chemistry , Amino Acid Sequence , Cell Transformation, Neoplastic/genetics , Cell Transformation, Neoplastic/metabolism , Chromatin/metabolism , HMGA Proteins/genetics , HMGA Proteins/metabolism , Humans , Methylation , Molecular Sequence Data , Phosphorylation , Protein Processing, Post-Translational , Protein Structure, Tertiary , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Spectrometry, Mass, Electrospray Ionization , Static Electricity
7.
Biochemistry ; 50(17): 3462-8, 2011 May 03.
Article in English | MEDLINE | ID: mdl-21417337

ABSTRACT

High mobility group A proteins (HMGA1 and HMGA2) are architectural factors involved in chromatin remodelling and regulation of gene expression. HMGA are highly expressed during embryogenesis and in cancer cells and are involved in development and cell differentiation as well as cancer formation and progression. These factors, by binding to DNA and interacting with other nuclear proteins, can organize macromolecular complexes involved in transcription, chromatin dynamics, RNA processing, and DNA repair. The identification of protein partners for HMGA has greatly contributed to our understanding of their multiple functions. He we report the identification of HMGA molecular partners using a gene fragment library in a phage display screening. Using an ORF-enriched cDNA library, we have isolated several HMGA1 interacting clones and for two of them, TBP associated factor 3 (TAF3) and chromatin assembly factor 1 p150/CAF-1, have demonstrated an in vivo association with HMGA1. The identification of these new partners suggests that HMGA can also influence general aspects of transcription and once more underlines their involvement in chromatin remodelling and dynamics.


Subject(s)
High Mobility Group Proteins/chemistry , Peptide Library , Amino Acid Sequence , Animals , Chromatin Assembly Factor-1/chemistry , DNA, Complementary/chemistry , HEK293 Cells , High Mobility Group Proteins/genetics , High Mobility Group Proteins/isolation & purification , Humans , Mice , Molecular Sequence Data , Mutation , Open Reading Frames , Protein Interaction Mapping , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Sequence Deletion , TATA-Binding Protein Associated Factors/chemistry
8.
ACS Med Chem Lett ; 1(6): 254-7, 2010 Sep 09.
Article in English | MEDLINE | ID: mdl-24900204

ABSTRACT

Protein carbamylation is of great concern both in vivo and in vitro. Here, we report the first structural characterization of a protein carbamylated at the N-terminal proline. The unexpected carbamylation of the α-amino group of the least reactive codified amino acid has been detected in high-resolution electron density maps of a new crystal form of the HIV-1 protease/saquinavir complex. The carbamyl group is found coplanar to the proline ring with a trans conformation. The reaction of N-terminal with cyanate ion derived from the chaotropic agent urea was confirmed by mass spectra analysis on protease single crystals. Implications of carbamylation process in vitro and in vivo are discussed.

9.
Biochim Biophys Acta ; 1799(1-2): 37-47, 2010.
Article in English | MEDLINE | ID: mdl-19732855

ABSTRACT

Nuclear functions rely on the activity of a plethora of factors which mostly work in highly coordinated molecular networks. The HMGA proteins are chromatin architectural factors which constitute critical hubs in these networks. HMGA are referred to as oncofetal proteins since they are highly expressed and play essential functions both during embryonic development and neoplastic transformation. A particular feature of HMGA is their intrinsically disordered status, which confers on them an unusual plasticity in contacting molecular partners. Indeed these proteins are able to bind to DNA at the level of AT-rich DNA stretches and to interact with several nuclear factors. In the post-genomic era, and with the advent of proteomic tools for the identification of protein-protein interactions, the number of HMGA molecular partners has increased rapidly. This has led to the extension of our knowledge of the functional involvement of HMGA from the transcriptional regulation field to RNA processing, DNA repair, and chromatin remodeling and dynamics. This review focuses mainly on the protein-protein interaction network of HMGA and its functional outcome. HMGA molecular partners have been functionally classified and all the information collected in a freely available database (http://www.bbcm.units.it/ approximately manfiol/INDEX.HTM).


Subject(s)
Chromatin Assembly and Disassembly/genetics , Gene Regulatory Networks , HMGA Proteins/metabolism , Transcription, Genetic , Animals , Humans , Models, Biological
10.
J Proteome Res ; 8(6): 2978-89, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19317492

ABSTRACT

HMGA is a family of nuclear proteins involved in a huge number of functions at the chromatin level. It consists of three members, HMGA1a, HMGA1b, and HMGA2, having high sequence homology and sharing the same structural organization (three highly conserved DNA-binding domains, an acidic C-terminal tail, and a protein-protein interaction domain). They are considered important nodes in the chromatin context, establishing a complex network of interactions with both promoter/enhancer sequences and nuclear factors. They are involved in a plethora of biological processes and their activities are finely tuned by several different post-translational modifications. We have performed an LC/MS screening on several different cell lines to investigate HMGA proteins expression and their post-translational modifications in order to detect distinctive modification patterns for each. Our analyses evidenced relevant macroscopic differences in the phosphorylation and methylation patterns of these proteins. These differences occur both within the HMGA family members and in the different cell types. Focusing on HMGA2, we have mapped its in vivo phosphorylation sites demonstrating that, similarly to the HMGA1 proteins, it is highly phosphorylated on the acidic C-terminal tail and that these modifications affect its DNA binding properties.


Subject(s)
HMGA Proteins/chemistry , HMGA2 Protein/chemistry , HMGA2 Protein/metabolism , HMGN Proteins/chemistry , Protein Processing, Post-Translational , Amino Acid Sequence , Cell Line, Tumor , Chromatography, Liquid , HMGA Proteins/genetics , HMGA Proteins/metabolism , HMGA2 Protein/genetics , HMGN Proteins/genetics , HMGN Proteins/metabolism , Humans , Mass Spectrometry , Methylation , Molecular Sequence Data , Neoplasms/metabolism , Phosphorylation , Protein Binding , Protein Interaction Mapping , Sequence Alignment , Serine/metabolism
11.
Proteomics ; 8(22): 4721-32, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18850631

ABSTRACT

The high mobility group A (HMGA) chromatin architectural transcription factors are a group of proteins involved in development and neoplastic transformation. They take part in an articulated interaction network, both with DNA and other nuclear proteins, organizing multimolecular complexes at chromatin level. Here, we report the development of a novel in vitro strategy for the identification of HMGA molecular partners based on the combination of an RP-HPLC prefractionation procedure, 2-DE gels, blot-overlay and MS. To demonstrate that our approach could be a reliable screening method we confirmed a representative number of interactions in vitro by GST pull-down and far-Western and in vivo by co-affinity purification. This approach allowed us to enlarge the HMGA molecular network confirming their involvement also in non-transcriptional-related processes such as RNA processing and DNA repair.


Subject(s)
Chromatin/metabolism , High Mobility Group Proteins/metabolism , Protein Interaction Domains and Motifs , Protein Interaction Mapping , Proteomics/methods , Animals , Cell Transformation, Neoplastic , Chromatography, Liquid , DNA Repair , Electrophoresis, Gel, Two-Dimensional , Gene Regulatory Networks , High Mobility Group Proteins/genetics , Humans , Immunoblotting , Mice , RNA Processing, Post-Transcriptional , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Tandem Mass Spectrometry
SELECTION OF CITATIONS
SEARCH DETAIL
...